Background: The coronavirus disease 2019 (COVID-19) pandemic has recently led to worldwide research efforts to identify subjects at greater risk of developing more severe illness: overall obesity displayed a strong correlation with critical illness and major severity of COVID-19 manifestations. Summary: Obesity and metabolic disorders are closely linked to chronic systemic inflammation. The adipose tissue constitutes a source of cytokines, which configure a low-grade inflammation and a hypercoagulation status; in addition, diagnosis and care of obese patients are often complicated by excess weight and ventilation difficulties. Key Messages: This review aims to examine the intersection between obesity and adverse outcomes of COVID-19, in order to investigate its preventive and/or therapeutic potential in the management of obesity-related COVID-19 complications.
Obes Facts

中文翻译：

---

COVID-19 和肥胖症：两种流行病的重叠

背景： 2019 年冠状病毒病 (COVID-19) 大流行最近导致全球范围内开展研究工作，以确定有更大风险患上更严重疾病的受试者：整体肥胖与危重疾病和 COVID-19 表现的主要严重程度密切相关。总结：肥胖和代谢紊乱与慢性全身炎症密切相关。脂肪组织构成细胞因子的来源，构成低度炎症和高凝状态；此外，肥胖患者的诊断和护理往往因体重过重和通气困难而变得复杂。关键信息：本综述旨在检查肥胖与 COVID-19 不良后果之间的交叉点，以研究其在肥胖相关 COVID-19 并发症管理中的预防和/或治疗潜力。
肥胖事实